Functional features of KPC-109, a novel 270-loop KPC-3 mutant mediating resistance to avibactam-based β-lactamase inhibitor combinations and cefiderocol
Vincenzo Di Pilato, Giulia Codda, Claudia Niccolai, Edward Willison, Joshua L. C. Wong, Erika Coppo, Gad Frankel, Anna Marchese, Gian María Rossolini
Topics & Concepts
Klebsiella pneumoniaeAvibactamBiologyCeftazidime/avibactamMicrobiologyAztreonamCeftazidimeCefepimePlasmidPiperacillinEscherichia coliAntibiotic resistanceGeneticsPseudomonas aeruginosaImipenemGeneAntibioticsBacteriaAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyInfections and bacterial resistance